LAP Score (Leukocyte Alkaline Phosphatase): Interpretation
🧪 LAP Score (Leukocyte Alkaline Phosphatase): Complete Guide
CML vs. Leukemoid Reaction · Staining · Reference Range · Interpretation
1. What Is the LAP Score? (Definition)
The Leukocyte Alkaline Phosphatase (LAP) score is a cytochemical test that measures the activity of alkaline phosphatase in neutrophils and their precursors.
Historically essential for distinguishing Chronic Myeloid Leukemia (CML) from a leukemoid reaction, the LAP score is still clinically useful when combined with peripheral smear findings—especially in environments where immediate molecular testing (e.g., BCR-ABL) is unavailable.
2. Purpose of the Test
✔ 1) Differentiate CML from Leukemoid Reaction
- CML: severely decreased LAP
- Leukemoid reaction: markedly elevated LAP
✔ 2) Assess neutrophil activation status
Infection, inflammation, pregnancy, and stress can elevate LAP.
✔ 3) Support diagnosis of specific hematologic disorders
Useful in MPNs (PV, ET), PNH, and marrow failure conditions.
3. Test Method (Alkaline Phosphatase Cytochemical Stain)
✔ 1) Specimen
- EDTA peripheral blood smear
✔ 2) Staining technique
A cytochemical alkaline phosphatase stain is applied.
After substrate breakdown, blue–dark blue granules appear in neutrophil cytoplasm.
✔ 3) Microscopic evaluation
- Evaluate 100 neutrophils (segmented + band forms)
- Score each cell 0–4 based on staining intensity:
| Score | Interpretation |
|---|---|
| 0 | No staining |
| 1 | Very faint |
| 2 | Mild–moderate |
| 3 | Strong |
| 4 | Very strong |
✔ 4) Total LAP Score
- Total = sum of 100 cells → 0–400
4. Reference Range
| LAP Score | Interpretation |
|---|---|
| 30–130 | Normal range |
| >130 | Increased (infection, inflammation, MPN) |
| <30 | Decreased (CML, PNH, severe anemia) |
5. Clinical Significance & Related Conditions
🟩 A. Conditions with Increased LAP
Associated with increased neutrophil activation.
- Leukemoid Reaction
- Severe bacterial infections, sepsis
- Tissue necrosis
- Tumor-related leukemoid response
- Myeloproliferative Neoplasms (MPN)
- Polycythemia vera (PV)
- Essential thrombocythemia (ET)
- Recovery phase of CML after treatment
- Other causes
- Pregnancy
- Stress, steroid therapy
- Acute hemorrhage
- Some hepatobiliary conditions
🟥 B. Conditions with Decreased LAP
- Chronic Myeloid Leukemia (CML)
- Classic finding: very low LAP (0–30)
- Seen with marked leukocytosis + left shift + basophilia
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Enzyme deficiency in specific neutrophil populations
- Aplastic anemia & severe anemia
- Medications
- Chlorpromazine
- Estrogens
- Certain cytotoxic drugs
6. Interpretation Pearls & Pitfalls
⚠ 1) Still meaningful even in the BCR-ABL era
Although molecular testing is gold standard for CML,
LAP remains useful in:
- Emergency settings
- Resource-limited environments
- Rapid smear-based assessments
⚠ 2) Sensitive to smear quality
Old smears, improper drying, or uneven staining → inaccurate scoring.
⚠ 3) LAP varies with physiologic status
Pregnancy & corticosteroid therapy can falsely elevate values.
⚠ 4) Must include band neutrophils in the 100-cell count
Excluding them leads to incorrect total scores.
7. Quick Summary Table
| Condition | LAP Score |
|---|---|
| CML | ↓↓ Very low |
| Leukemoid reaction | ↑ High |
| PV / ET | ↑ |
| PNH | ↓ |
| Pregnancy / Steroid use | ↑ |
8. References
- Bain BJ. Blood Cells: A Practical Guide, 6th ed. Wiley-Blackwell.
- Rodak BF et al. Hematology: Clinical Principles and Applications, 6th ed.
- Hoffbrand AV. Postgraduate Hematology, 7th ed.
- CLSI. Peripheral Blood Smear Evaluation Guidelines.
- WHO. Classification of Tumours of Haematopoietic and Lymphoid Tissues, 5th ed.